Related Experiment Video
Updated: May 13, 2026

In Vivo Mouse Model of Spinal Implant Infection
Published on: June 23, 2020
Is vancomycine still a choice for chronic osteomyelitis empirical therapy in iran?
Morteza Izadi1, Mohammad Mahdi Zamani, Seyed Ahmad Mousavi
1Health Research Center (HRC), Baqiyatallah University of Medical Sciences, Tehran, IR Iran.
Background:
Pyogenic bacteria and especially Staphylococcus aurous (S. aurous) are the most common cause of chronic osteomyelitis. Not only treatment protocol of chronic osteomyelitis occasionally is amiss but also this malady responds to treatment difficultly.
Objectives:
This study investigates antibiotic resistance pattern of S. aurous isolated from Iranian patients who suffer from chronic osteomyelitis by two methods: disk diffusion (Kirby bauyer) and E-test (Epsilometer test) to find Vancomycin susceptibility and MIC (Minimum inhibitory concentration).
Patients And Methods:
One hundred and thirty one patients who suffer from chronic osteomyelitis which have been referred to both governmental and private hospitals at 2010 were tried out for culturing of osteomyelitis site (sites). Antibiotic susceptibility and MIC of isolated bacteria were investigated by Kirby bauyer and E-test respectively.
Results:
Samples were collected from bone (73.4%), surrounding tissue (14.6%) and wound discharge (12%). S. aureus was isolated from 49.6% of the samples. According to disc diffusion, methicillin resistance S. aureus (MRSA) was 75% and Vancomycin resistance S. aurous (VRSA) was 0% and based on MIC, MRSA was 68.5% and VRSA was 0%. According to MIC experiments, maximum sensitivity was against to Vancomycin (90.2%) and ciprofloxacin (54.4%) respectively but based on disc diffusion, maximum sensitivity was against to Vancomycin (97.7%) and ciprofloxacin (43.2%), respectively (P = 0.001). E-test (9.8%) in comparison with Disc diffusion (2.3%) showed higher percent of intermediate susceptibility to Vancomycin (P = 0.017).
Conclusions:
Comparison of antibiograms and MICs showed that Kirby bauyer technique especially for detection of VISA strains is not reliable comparison with E-test. Already VRSA strains have not detected in Iranian chronic osteomyelitis, Thus Vancomycin is the first choice for chronic osteomyelitis empirical therapy in Iran yet.
Insights
Antibiotic resistance in Staphylococcus aureus is a significant challenge in chronic osteomyelitis treatment. The E-test is more reliable than disk diffusion for determining Vancomycin susceptibility, with no Vancomycin-resistant strains detected in Iranian patients.
Area of Science:
- Medical Microbiology
- Infectious Diseases
- Clinical Pharmacy
Background:
- Chronic osteomyelitis is primarily caused by pyogenic bacteria, particularly Staphylococcus aureus.
- Treatment of chronic osteomyelitis is often challenging due to difficult-to-treat infections.
Purpose of the Study:
- To investigate the antibiotic resistance patterns of Staphylococcus aureus in Iranian patients with chronic osteomyelitis.
- To compare the efficacy of disk diffusion (Kirby-Bauer) and E-test methods for determining antibiotic susceptibility and Minimum Inhibitory Concentration (MIC).
Main Methods:
- Culturing of infection sites from 131 chronic osteomyelitis patients.
- Antibiotic susceptibility testing and MIC determination using Kirby-Bauer disk diffusion and E-test.
- Focus on Vancomycin susceptibility and identification of Methicillin-resistant S. aureus (MRSA) and Vancomycin-resistant S. aureus (VRSA).
Main Results:
- Staphylococcus aureus was isolated from 49.6% of samples.
- MRSA prevalence was 75% by disk diffusion and 68.5% by MIC.
- No Vancomycin-resistant S. aureus (VRSA) strains were detected.
- Vancomycin showed high sensitivity (90.2% by MIC, 97.7% by disk diffusion).
- E-test demonstrated higher intermediate susceptibility to Vancomycin (9.8%) compared to disk diffusion (2.3%).
Conclusions:
- The E-test is more reliable than the Kirby-Bauer disk diffusion method for detecting Vancomycin-Intermediate S. aureus (VISA) strains.
- The absence of VRSA in this cohort suggests Vancomycin remains a primary empirical treatment choice for chronic osteomyelitis in Iran.
Related Concept Videos
Endocarditis III: Medical Management
Antibiotic Selection
Antimicrobial Effectiveness
Clinical Significance of Antibiotic Resistance
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
Endocarditis IV: Nursing Management
